BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37962879)

  • 1. Genome-Wide Polygenic Risk Score for CKD in Individuals with APOL1 High-Risk Genotypes.
    Vy HMT; Coca SG; Sawant A; Sakhuja A; Gutierrez OM; Cooper R; Loos RJF; Horowitz CR; Do R; Nadkarni GN
    Clin J Am Soc Nephrol; 2024 Mar; 19(3):374-376. PubMed ID: 37962879
    [No Abstract]   [Full Text] [Related]  

  • 2. Including APOL1 alleles and ancestry adjustments improve a genome-wide polygenic CKD score.
    Yu Z; Wuttke M
    Kidney Int; 2022 Nov; 102(5):954-955. PubMed ID: 35985372
    [No Abstract]   [Full Text] [Related]  

  • 3. Genome-wide polygenic score to predict chronic kidney disease across ancestries.
    Khan A; Turchin MC; Patki A; Srinivasasainagendra V; Shang N; Nadukuru R; Jones AC; Malolepsza E; Dikilitas O; Kullo IJ; Schaid DJ; Karlson E; Ge T; Meigs JB; Smoller JW; Lange C; Crosslin DR; Jarvik GP; Bhatraju PK; Hellwege JN; Chandler P; Torvik LR; Fedotov A; Liu C; Kachulis C; Lennon N; Abul-Husn NS; Cho JH; Ionita-Laza I; Gharavi AG; Chung WK; Hripcsak G; Weng C; Nadkarni G; Irvin MR; Tiwari HK; Kenny EE; Limdi NA; Kiryluk K
    Nat Med; 2022 Jul; 28(7):1412-1420. PubMed ID: 35710995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Genetic Characteristics of CKD Patients with High-Risk APOL1 Genotypes.
    Elliott MD; Marasa M; Cocchi E; Vena N; Zhang JY; Khan A; Krishna Murthy S; Bheda S; Milo Rasouly H; Povysil G; Kiryluk K; Gharavi AG
    J Am Soc Nephrol; 2023 May; 34(5):909-919. PubMed ID: 36758113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study.
    Gutiérrez OM; Irvin MR; Zakai NA; Naik RP; Chaudhary NS; Estrella MM; Limou S; Judd SE; Cushman M; Kopp JB; Winkler CA
    Am J Kidney Dis; 2020 Jan; 75(1):54-60. PubMed ID: 31563468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Epistatic Interaction between
    Vy HMT; Lin BM; Gulamali FF; Kooperberg C; Graff M; Wong J; Campbell KN; Matise TC; Coresh J; Thomas F; Reiner AP; Nassir R; Schnatz PF; Johns T; Buyske S; Haiman C; Cooper R; Loos RJF; Horowitz CR; Gutierrez OM; Do R; Franceschini N; Nadkarni GN
    Clin J Am Soc Nephrol; 2022 Oct; 17(10):1522-1525. PubMed ID: 35948364
    [No Abstract]   [Full Text] [Related]  

  • 7. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
    Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.
    Robertson CC; Gillies CE; Putler RKB; Ng D; Reidy KJ; Crawford B; Sampson MG
    Nephrol Dial Transplant; 2017 Dec; 32(12):2051-2058. PubMed ID: 27638911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein L1 Genotypes and the Association of Urinary Potassium Excretion with CKD Progression.
    Ilori TO; Liu J; Rodan AR; Verma A; Mills KT; He J; Winkler CA; Dupuis J; Anderson CAM; Waikar SS
    Clin J Am Soc Nephrol; 2022 Oct; 17(10):1477-1486. PubMed ID: 36400568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.
    Hung AM; Assimon VA; Chen HC; Yu Z; Vlasschaert C; Triozzi JL; Chan H; Wheless L; Wilson O; Shah SC; Mack T; Thompson T; Matheny ME; Chandrasekar S; Mozaffari SV; Chung CP; Tsao P; Susztak K; Siew ED; Estrada K; Gaziano JM; Graham RR; Tao R; Hoek M; Robinson-Cohen C; Green EM; Bick AG;
    J Am Soc Nephrol; 2023 Nov; 34(11):1889-1899. PubMed ID: 37798822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low prevalence of apolipoprotein L1 gene variants in Black South Africans with hypertension-attributed chronic kidney disease
.
    Nqebelele NU; Dickens C; Dix-Peek T; Duarte R; Naicker S
    Clin Nephrol; 2019 Jan; 91(1):40-47. PubMed ID: 30369398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOL1 risk allele variants are absent in Indian patients with chronic kidney disease.
    Yadav AK; Kumar V; Sinha N; Jha V
    Kidney Int; 2016 Oct; 90(4):906-7. PubMed ID: 27633872
    [No Abstract]   [Full Text] [Related]  

  • 13.
    Chen TK; Tin A; Peralta CA; Appel LJ; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
    Clin J Am Soc Nephrol; 2017 Nov; 12(11):1771-1777. PubMed ID: 29051146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host factors predisposing to kidney disease in people with HIV.
    Hung RKY; Winkler CA; Post FA
    Curr Opin HIV AIDS; 2023 Mar; 18(2):87-92. PubMed ID: 36722197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenome-wide analysis reveals epistatic associations between APOL1 variants and chronic kidney disease and multiple other disorders.
    Adamson WE; Noyes H; Johnson P; Cooper A; Monckton DG; Ogunsola J; Beckett-Hill G; Sullivan M; Mark P; Parekh RS; MacLeod A
    EBioMedicine; 2024 Mar; 101():105000. PubMed ID: 38360481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Kidney Function Decline Associated with APOL1 Genotypes: Results from AASK.
    Tin A; Grams ME; Estrella M; Lipkowitz M; Greene TH; Kao WHL; Li L; Appel LJ
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1353-1359. PubMed ID: 27230965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Genetic Polymorphisms of TGF-β1, HMOX1, and APOL1 With CKD in Nigerian Patients With and Without HIV.
    Ekrikpo UE; Mnika K; Effa EE; Ajayi SO; Okwuonu C; Waziri B; Bello A; Dandara C; Kengne AP; Wonkam A; Okpechi I
    Am J Kidney Dis; 2020 Jul; 76(1):100-108. PubMed ID: 32354559
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Chaudhary NS; Moore JX; Zakai NA; Judd SE; Naik RP; Limou S; Cushman M; Lange LA; Wang HE; Winkler CA; Irvin MR; Kopp JB; Gutiérrez OM
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1733-1740. PubMed ID: 31704668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A focus on the association of Apol1 with kidney disease in children.
    Ekulu PM; Nkoy AB; Adebayo OC; Kazadi OK; Aloni MN; Arcolino FO; Ngiyulu RM; Gini JE; Lepira FB; Van den Heuvel LP; Levtchenko EN
    Pediatr Nephrol; 2021 Apr; 36(4):777-788. PubMed ID: 32253519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals: A Randomized Clinical Trial.
    Nadkarni GN; Fei K; Ramos MA; Hauser D; Bagiella E; Ellis SB; Sanderson S; Scott SA; Sabin T; Madden E; Cooper R; Pollak M; Calman N; Bottinger EP; Horowitz CR
    JAMA Netw Open; 2022 Mar; 5(3):e221048. PubMed ID: 35244702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.